NM_004370.6:c.3994delG
Variant summary
Our verdict is Pathogenic. The variant received 12 ACMG points: 12P and 0B. PVS1PM2PP5_Moderate
The NM_004370.6(COL12A1):c.3994delG(p.Ala1332LeufsTer12) variant causes a frameshift change involving the alteration of a conserved nucleotide. The variant was absent in control chromosomes in GnomAD project. Variant has been reported in ClinVar as Pathogenic (★). Variant results in nonsense mediated mRNA decay.
Frequency
Consequence
NM_004370.6 frameshift
Scores
Clinical Significance
Conservation
Publications
- Bethlem myopathy 2Inheritance: AD Classification: STRONG, SUPPORTIVE Submitted by: Labcorp Genetics (formerly Invitae), Orphanet
- Bethlem myopathy 2Inheritance: AD Classification: STRONG, LIMITED Submitted by: Ambry Genetics, Illumina, Genomics England PanelApp
- Ullrich congenital muscular dystrophy 2Inheritance: AR Classification: STRONG Submitted by: Labcorp Genetics (formerly Invitae)
- Bethlem myopathyInheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
- Ullrich congenital muscular dystrophyInheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
Genome browser will be placed here
ACMG classification
Our verdict: Pathogenic. The variant received 12 ACMG points.
Variant Effect in Transcripts
ACMG analysis was done for transcript: NM_004370.6. You can select a different transcript below to see updated ACMG assignments.
RefSeq Transcripts
| Selected | Gene | Transcript | Tags | HGVSc | HGVSp | Effect | Exon Rank | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|---|
| COL12A1 | NM_004370.6 | MANE Select | c.3994delG | p.Ala1332LeufsTer12 | frameshift | Exon 20 of 66 | NP_004361.3 | ||
| COL12A1 | NM_001424113.1 | c.3994delG | p.Ala1332LeufsTer12 | frameshift | Exon 20 of 66 | NP_001411042.1 | |||
| COL12A1 | NM_001424114.1 | c.3994delG | p.Ala1332LeufsTer12 | frameshift | Exon 20 of 65 | NP_001411043.1 |
Ensembl Transcripts
| Selected | Gene | Transcript | Tags | HGVSc | HGVSp | Effect | Exon Rank | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|---|
| COL12A1 | ENST00000322507.13 | TSL:1 MANE Select | c.3994delG | p.Ala1332LeufsTer12 | frameshift | Exon 20 of 66 | ENSP00000325146.8 | ||
| COL12A1 | ENST00000345356.10 | TSL:1 | c.502delG | p.Ala168LeufsTer12 | frameshift | Exon 5 of 51 | ENSP00000305147.9 | ||
| COL12A1 | ENST00000483888.6 | TSL:5 | c.3994delG | p.Ala1332LeufsTer12 | frameshift | Exon 20 of 65 | ENSP00000421216.1 |
Frequencies
GnomAD3 genomes Cov.: 32
GnomAD4 exome Cov.: 31
GnomAD4 genome Cov.: 32
ClinVar
Submissions by phenotype
Bethlem myopathy 2;C4225314:Ullrich congenital muscular dystrophy 2 Pathogenic:1
This variant is not present in population databases (ExAC no frequency). For these reasons, this variant has been classified as Pathogenic. Loss-of-function variants in COL12A1 are known to be pathogenic (PMID: 24334604, 24334769, 27159402, 27348394, 224334604). This variant has not been reported in the literature in individuals with COL12A1-related disease. This sequence change creates a premature translational stop signal (p.Ala1332Leufs*12) in the COL12A1 gene. It is expected to result in an absent or disrupted protein product.
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at